SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

PHARMANET GROUP LIMITED (PNO)

Former Name ASX

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

Shareholder links

Our website ranking of PNO: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Registry Services Level 5 126 Phillip Street Sydney NSW 2000

Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
Fax :
RegistryWebsite RegistryEmail

Company details

Address: 108 Outram Street, West Perth, 6005
Tel:  +61 8 9486 7244 Fax: +61 8 9463 6373

Date first listed: 13/03/1987
Company Secretary: James Carter
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Provision of IT&T solutions, specifically electronic commerce applications to the health care industry and continuing the manufacture and distribution of its pharmaceutical product.

name changed to Calidus Resources Limited

15/06/2017

Calidus Resources Limited (formerly Pharmanet Group Limited) is pleased to advise that it successfully closed the oversubscribed offer to raise $7,875,000 via prospectus dated 5 May 2017 on the Closing Date of 1 June 2017.

13/06/2017

The company releases the results of its meeting.

30/05/2017

The company has lodged with the ASIC a prospectus for its offer to the public of 350 million shares at an issue price of $0.02 each and 87.5 million options at an issue price of $0.01 each to raise a total of $7.85 million.

08/05/2017

The 2016 Annual General Meeting of the Company will be held at 108 Outram Street, West Perth, Western Australia on Tuesday, 30 May 2017 at 10.30am (WST).

01/05/2017

The 2015 Annual General Meeting of the Company will be held at 108 Outram Street, West Perth, Western Australia on Tuesday, 30 May 2017 at 10.00am (WST).

01/05/2017

The company has completed a placement to raise a total of $620,000. Strong demand confirms market support for the acquisition of the Warrawoona Gold Project. The targeted exploration program and drilling at Warrawoona will be accelerated.

18/04/2017

The company lodges its Half Year Report 31 December 2016.

27/03/2017

The company has entered into a conditional binding agreement to acquire 100% of Keras Gold Australia. Keras Australia controls the Warrawoona Gold Project. It is a wholly owned subsidiary of Keras Resources plc.

22/03/2017

The final payment due under the terms of the DOCA has been received.Following payment of these funds, the DOCA was wholly effectuated on 7 March 2017. The Company has complied with all the terms of the DOCA and control of the Company has reverted to the recently appointed Board of Directors.

07/03/2017

we understand that on or about this date the company consolidated its shares 1 for 300

22/02/2017

The fully paid ordinary shares of the company have been consolidated on a 1 for 300 basis as approved by shareholders at the general meeting of shareholders. Notices to existing shareholders detailing their pre and post consolidation share holdings will be mailed on 22 February 2017.

17/02/2017

The company provides an update regarding its consolidation - consolidation resolution was approved by shareholders.

10/02/2017

The company releases the results of its general meeting.

10/02/2017

Shareholders get 1 share for every 300 presently owned.

13/01/2017

A General Meeting of the Company will be held at the offices of Palisade Business Consulting Pty Ltd, 22 Lindsay Street, Perth, Western Australia on Friday, 10 February 2017 at 10am (WST).

11/01/2017

The company lodges its Annual Report and Financial Statements for FYE 30 June 2016.

19/12/2016

The company lodges its Financial Statements for the Half Year Ended 31 Dec 2015.

19/12/2016

The company lodges its Annual Report and Financial Statements for FYE 30 June 2015.

19/12/2016

The company lodges its Financial Statements for Half Year Ended 31 December 2014.

19/12/2016

The Deed Administrator and the Proponent have agreed to extend the due date of the DOCA to 30 May 2017. Other than the extension to the due date, the DOCA continues in full force and effect.

13/12/2016

Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Monday 22 August 2016 will have its securities suspended from official quotation before the commencement of trading on Tuesday 23 August 2016. The company has not paid its annual listing fees in respect of the year ending 30 June 2017 but the securities are already suspended from official quotation.

23/08/2016

The Company executed the DOCA with Otsana Pty Ltd on 21 June 2016. A copy of the DOCA has been lodged with the ASIC.

22/06/2016

Following an application by the Company, the Supreme Court of Western Australia ordered that the adjournment period pursuant to Section 439B(2) of the Corporations Act 2001 in which the reconvened second meeting of creditors must be held be extended to 30 May 2016.

28/04/2016

Following an application by the Company, the Supreme Court of Western Australia ordered that the adjournment period pursuant to Section 439B(2) of the Corporations Act 2001 in which the reconvened second meeting of creditors must be held be extended to 29 April 2016.

04/03/2016

Following an application by the Company, the Supreme Court of Western Australia ordered that the adjournment period pursuant to Section 439B(2) of the Corporations Act 2001 in which the reconvened second meeting of creditors must be held be extended to 1 March 2016.

30/11/2015

Following an application by the Company, the Supreme Court of Western Australia ordered that the adjournment period pursuant to Section 439B(2) of the Corporations Act 2001 in which the reconvened second meeting of creditors must be held be extended to 27 November 2015.

02/11/2015

Following an application by the Company, the Supreme Court of Western Australia ordered that the adjournment period pursuant to Section 439B(2) of the Corporations Act 2001 in which the second meeting of creditors must be reconvened be extended to 27 October 2015.

17/09/2015

The following entity (Pharmanet Group Limited) has not paid their annual listing fees in respect of the year ending 30 June 2016 but the securities are already suspended from official quotation. Under listing rule 17.15, any entity that has not paid its annual listing fees as required by listing rule 16.5 by 5.00 pm AEST on Monday 31 August 2015 will be removed from the official list with effect from the close of trading on Monday 31 August 2015

25/08/2015

Following an application by the Company, the Supreme Court of Western Australia ordered that the adjournment period pursuant to Section 439B(2) of the Corporations Act 2001 in which the second meeting of creditors must be reconvened be extended to 25 September 2015.

22/07/2015

At the second meeting of creditors of the Company held on 21 May 2015, creditors resolved that the meeting be adjourned for a period of not more than 45 business days.

21/05/2015

Jack James of Palisade Business Consulting Pty Ltd was appointed Voluntary Administrator of the Company on 15 April 2015 pursuant to a resolution passed by the Board of Directors of the Company

15/04/2015

advises that at the duly convened Annual General Meeting of the members of the company, all resolutions put to the members were passed.

26/11/2014

the Annual General Meeting of the Company will be held in the John Worsfold Room, at Level 3, Gate 12, Roberts Road, Subiaco, Western Australia on Wednesday, the 26th day of November 2014 commencing at 10.30am WST

24/10/2014

releases September 2014 Quarter Shareholder Update

23/10/2014

The securities of Pharmanet Group Limited (the "Company") will be suspended from quotation from the commencement of trading tomorrow, Tuesday, 7 October 2014, at the request of the Company, pending the release of an announcement. Security Code: PNO PNOO

06/10/2014

Deferred settlement trading of the securities of Pharmanet Group Limited (PNONA and PNOOB) (the "Company") will be suspended from quotation immediately due to the Company not proceeding with its non-renounceable offer. Security Codes: PNONA PNOOB

26/08/2013

the suspension of trading in the securities of Pharmanet Group Limited (the "Company") will be lifted immediately, following receipt of an announcement in relation to a capital raising and placement

29/08/2011

securities suspended pending an announcement

25/08/2011

name changed from Pharmanet Online Limited

11/03/2004

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments
When is the next meeting with creditors and what outcome can be expected for shareholders15/07/2015 16:25:35

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    07/11/2011John Palermo30,000,000$0.005$151,155

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Keith CoughlanNon Exec Chairman13/06/2017
    David ReevesManaging Director13/06/2017
    Adam MiethkeNon Exec Director07/03/2017
    Peter Hepburn-BrownNon Exec Director13/06/2017

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Brendan de KauweDirector07/03/201713/06/2017
    Nicholas YoungDirector07/03/201713/06/2017
    John FoundDirector28/11/200807/03/2017
    Christopher QuirkDirector26/06/200607/03/2017
    John PalermoChairman27/11/200217/03/2015

    Date of first appointment, title may have changed.